Omega-3 fatty acids' supplementation in Alzheimer's disease: A systematic review
Canhada S, Castro K, Perry IS, Luft VC
Nutritional neuroscience · 96 citas
Etiquetas de revisión
Financiación no declaradaDatos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.
Cómo se estudió
- Diseño
- Revisión sistemática (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Marcadores de salud y funcionamiento
Quién lo pagó
- Financiación
- Financiación no declarada
Publicación
- Publicado
- 2017-05-03 · Nutr Neurosci · vol. 21 · número 8 · págs. 529–538
- Editorial
- Taylor & Francis
- Citado
- 158 citas · más que el 92% de estudios similares · 1.4× el promedio de su campo
- Impacto
- Entre el 10 % más citado de su campo
- Referencias
- 35 trabajos
- Acceso
- De pago
- Áreas de investigación
- Fatty Acid Research and Health · Nutritional Studies and Diet · Metabolomics and Mass Spectrometry Studies
- Palabras clave
- Disease, Medicine, Alzheimer's disease, Neuroscience, Internal medicine, Psychology
- MeSH
- animals, fishes, humans, alzheimer disease, fatty acids, omega-3, fish oils, neuroprotective agents, nootropic agents, anti-inflammatory agents, non-steroidal, severity of illness index, reproducibility of results, patient compliance, cognition, evidence-based medicine, dietary supplements, seafood, controlled clinical trials as topic, diet, healthy
4 autores
- Scheine Canhada🇧🇷 · autor de correspondenciaUniversidade Federal do Rio Grande do Sul
- Kamila Castro🇧🇷Universidade Federal do Rio Grande do Sul; Hospital de Clínicas de Porto Alegre
- Ingrid Schweigert Perry🇧🇷Universidade Federal do Rio Grande do Sul; Hospital de Clínicas de Porto Alegre; Universidade do Extremo Sul Catarinense
- Vivian Cristine Luft🇧🇷Universidade Federal do Rio Grande do Sul; Hospital de Clínicas de Porto Alegre
Resumen
El texto original del estudio, en el idioma en que se publicó.
Introduction
Alzheimer's disease (AD) is a neurodegeneration disorder characterized by progressive impairments of memory, language, reasoning, and other cognitive functions. Evidence suggests that omega-3 fatty acids may act as a possible protection factor in AD.
Objective
To evaluate the results available in the literature involving omega-3 fatty acids supplementation and its effect on cognitive function in AD patients.
Methods
A systematic review of MEDLINE (from PubMed), Excerpta Medica Database, and Cochrane Library databases was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Inclusion criteria consisted in original intervention studies, controlled by placebo, that assessed the impact of supplementation or dietary intake of omega-3 fatty acids on cognitive function, in humans with AD, without limitation for prime date of publication.
Results
Initial search resulted in 361 articles. Seven studies fully met the inclusion criteria. Most studies did not find statistically significant results for the omega-3 fatty acids supplementation compared to placebo, and those who show some benefit do it only in a few cognitive assessment scales. However, the effects of omega-3 fatty acids appear to be most effectively demonstrated in patients with very mild AD.
Conclusion
The effects of omega-3 fatty acids supplementation in mild AD corroborate epidemiological observational studies showing that omega-3 fatty acids may be beneficial in disease onset, when there is slight impairment of brain function. Although some studies have shown changes in scales of cognitive function in more severe cases, they are not enough to support omega-3 fatty acids supplementation in the treatment of AD.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.